Back

Identification of a novel tedizolid resistance mutation in rpoB of methicillin-resistant Staphylococcus aureus

Shen, T.; Penewit, K.; Waalkes, A.; Xu, L.; Salipante, S.; Nath, A.; Werth, B. J.

2019-11-01 microbiology
10.1101/827501 bioRxiv
Show abstract

A tedizolid-resistant isolate of MRSA was selected by serial passage. Whole genome sequencing revealed only a single nucleotide variant in rpoB. Cross-resistance to linezolid, chloramphenicol, and quinupristin-dalfopristin was observed but susceptibility to other drugs including rifampin was unchanged. Models of the RNA-polymerase-ribosomal complex revealed that the mutated residue was unlikely to interact directly with the oxazolidinone binding site. This is the first time that rpoB mutation has been associated with resistance to the PhLOPSa antimicrobials.

Matching journals

The top 1 journal accounts for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.